US 9481662
Seriniquinones, melanoma-specific anticancer agents
granted A61KA61K31/381A61P
Quick answer
US patent 9481662 (Seriniquinones, melanoma-specific anticancer agents) held by The Regents of the University of California expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/381, A61P, A61P35/00